News
While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston ...
The FDA said some of Boston Scientific ’s Endotak Reliance defibrillator wires can become calcified, which may stop the ...
The US Food and Drug Administration recently published an alert regarding Boston Scientific’s Watchman product, a heart ...
The specifics surrounding the incidents involve the access systems used during implantation procedures for sedated patients ...
The FDA is reviewing Boston Scientific's defibrillator leads after reports of rising shock impedance and 16 related deaths.
The update covers devices used in procedures to implant the company’s Watchman heart device.
The FDA has issued an early communication to warn of updated instructions for use for certain Boston Scientific Watchman access systems.
The FDA has issued an alert regarding a safety concern with certain Boston Scientific defibrillator leads used in implantable cardioverter defibrillators. The affected models include Endotak Reliance, ...
A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...
Boston Scientific Corporation (NYSE:BSX) is one of the most profitable growth stocks to buy according to billionaires. On ...
From harnessing AI to integrating complex workflows, biotech leader Cytiva doesn’t just supply tools for drug discovery—it ...
The FDA has issued an alert about a potentially high-risk issue involving models of Boston Scientific’s Watchman Access Systems, which are used to provide vascular and transseptal access during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results